Wedbush analyst, Liana Moussatos, cut her PT on Pacira Pharmaceuticals (NASDAQ: PCRX) to $105 from $113 after April Symphony Health ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE